Skip to main content
. 2020 Jun 24;18:272–281. doi: 10.1016/j.omto.2020.06.016

Figure 2.

Figure 2

Persistence of CD28- and 4-1BB-Based CAR-T Cells in Tumor-Bearing Mice

(A) Number of CAR-T cells in the peripheral blood of tumor-bearing mice infused with CD28- or 4-1BB-based CAR-T cells at high dose for different time intervals. (B) Number of CAR-T cells in peripheral blood after CAR-T cell injection at low dose. ∗∗p < 0.01, and the error bars represent the standard derivation.